Clinical Trials Directory

Trials / Completed

CompletedNCT00174317

Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip

Clinical Protocol For A Multicentre, Double-Blind, Randomised, Parallel Group Study To Compare The Efficacy and Tolerability Of Celecoxib Vs. Diclofenac In The Treatment Of Subjects With Osteoarthritis Of The Hip Requiring Joint Replacement Therapy

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
250 (planned)
Sponsor
Pfizer · Industry
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

To determine if celecoxib 200 mg once daily is as effective as diclofenac 50 mg three times daily in the treatment of pain symptoms associated with osteoarthritis of the hip

Conditions

Interventions

TypeNameDescription
DRUGCelecoxib
DRUGDiclofenac

Timeline

Start date
2003-08-01
Completion
2005-02-01
First posted
2005-09-15
Last updated
2006-12-05

Locations

44 sites across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00174317. Inclusion in this directory is not an endorsement.

Celecoxib Versus Diclofenac In The Treatment Of Osteoarthritis Of The Hip (NCT00174317) · Clinical Trials Directory